ACTA1 and cancer: It is also necessary to develop panels containing MDSCs markers as well as other markers like CD19 (B cells), Granzyme B (activated T cells), Foxp3 (regulatory T cells), α-SMA (cancer associated fibroblasts, CAFs) and FAP (CAFs) to characterize the TME.